Back to Agenda
TOPIC 5 SESSION 4: Post-authorisation Development Plan (PASS/PAES)
Session Chair(s)
Gaby L. Danan, MD, PHD
Pharmacovigilance Expert, GLD, France
Phil Tregunno
Deputy Director - Patient Safety Monitoring, Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Speaker(s)
Jan Petracek, MD, MSC
CEO, iVigee Services a.s., Czech Republic
Post-authorisation Development Plan (PASS/PAES)
Have an account?